January 1, Pay-To-Play: FDA Chiefs Land Lavish Moderna Jobs For Greenlighting COVID Shots

When it came time for the experimental COVID jabs to be approved, two high-level regulatory officials within the FDA were all in. Conveniently enough, mere months later they landed cushy, high paying jobs at vaccine maker Moderna – effectively acting as bribes for their blind support for the jabs!

A New British Medical Journal (BMJ) investigation uncovered that the FDA regulators had scored gigs at Moderna and questioned how the FDA could ever be impartial when the individuals within it could be so easily bribed.

One of the regulators is Dr. Doran Fink, a “physician/scientist experienced in regulation and clinical development/licensure of vaccines and related biological products” who was heavily involved in regulating vaccines at the FDA for 12+ years.

During the COVID pandemic, Dr. Fink was one of the loudest voices on the COVID vaccines, speaking on behalf of the FDA at several meetings with the agency’s vaccine advisors focused on discussing things like if the vaccines and subsequent boosters should be approved.

Fink also spoke at meetings held by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices—a group of “health experts” that were responsible for developing recommendations on how the vaccines should be put to use.

Some of his key responsibilities with the FDA throughout the pandemic were to advise vaccine makers on vaccine development and coordinate “expedited review of regulatory submissions,” advise U. S. government stakeholders outside the FDA on COVID vaccine science and development, and contributed to FDA guidance on the development, licensure, and emergency use authorization of COVID-19 vaccines.

Basically Fink was the guy that Big Pharma dreamt about having in their pocket to help get their experimental injections approved – so they bought his loyalty.

According to Fink’s LinkedIn profile, he left the FDA in December 2022 and started a job at Moderna as the head of “Translational Medicine and Early Clinical Development, Infectious Diseases” in February 2023.

The other regulator was Dr. Jaya Goswami who had a similar history but a shorter tenure with the FDA – not that it mattered.

Dr. Goswami began working as a medical officer at the FDA’s Center for Biologics Evaluation and Research in March 2020 and had “broad oversight over vaccines and biologics clinical development,” according to the BMJ report.

Goswami was specifically responsible for signing off on Moderna’s COVID vaccine clinical data and ensuring that it met “regulatory standards for approval.”

Moderna must have had doubts about their clinical data, so they paid him off as well.

The company’s SPIKEVAX received FDA approval in January 2022 and Goswami left the FDA in June 2022 to begin working for Moderna that same month as their director of clinical development in infectious diseases.

Moderna reported that they made $18.5 billion in 2021 from sales of its COVID-19 vaccine, more than $19 billion in 2022, and projects sales of its COVID-19 vaccine will reach at least $6 billion in 2023.

All of it was made possible by these two highly corrupt FDA regulators that lined their pockets in exchange for helping this Pharmaceutical giant get away with selling an EXTREMELY questionable experimental injection to the American public.

Why It Matters

The shocking revelation of FDA regulators landing high-paying jobs at Moderna after approving their COVID jabs raises serious concerns about the integrity of our health institutions. These individuals put their personal gain above the safety of the American people. The potential bribery of regulators undermines public trust in the FDA and the vaccines themselves.

With billions of dollars at stake, it’s crucial to question if these experimental injections were approved based on merit or if Big Pharma’s deep pockets swayed the decision. We must demand transparency and accountability to ensure the health of our nation isn’t compromised by greed and corruption.

As our loyal readers, we encourage you to share your thoughts and opinions on this issue. Let your voice be heard and join the discussion below.

Source